NCT07224828

Brief Summary

A clinical research study design to compare the effectiveness of a battery toothbrush and dentifrice in reducing gingivitis and dental plaque in adults.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Oct 2025

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 14, 2025

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

November 4, 2025

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 5, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 28, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 28, 2026

Completed
Last Updated

February 6, 2026

Status Verified

February 1, 2026

Enrollment Period

4 months

First QC Date

November 4, 2025

Last Update Submit

February 4, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Löe and Silness Gingival Index

    score from 0 to 3 will be assigned by the examining dentist to all scorable surfaces of the maxillary and mandibular teeth using a dental light and dental mirror. A whole mouth mean score for each subject will be determined by adding the values given by the examining dentist to each scorable surface and dividing that number by the total number of surfaces scored.

    baseline,6 week, 12 week

  • Rustogi Mod. Navy Plaque Index

    An expanded form of the Rustogi Modified Navy Plaque Index, used to measure plaque on different surfaces of teeth. Plaque disclosing solution used

    baseline, 6 week, 12 week

Study Arms (3)

Test 1

EXPERIMENTAL

instructed to brush their teeth for two (2) minutes twice a day (morning and evening) with the toothpaste and toothbrush provided.

Drug: Total Active Prevention Fresh Toothpaste + Colgate Total Active Prevention Battery Toothbrush

Test 2

ACTIVE COMPARATOR

instructed to brush their teeth for two (2) minutes twice a day (morning and evening) with the toothpaste and toothbrush provided.

Drug: Colgate Great Regular + Total Active Prevention Battery Toothbrush

Test 3

ACTIVE COMPARATOR

instructed to brush their teeth for two (2) minutes twice a day (morning and evening) with the toothpaste and toothbrush provided.

Drug: Colgate Great Regular + standard reference flat trim toothpaste

Interventions

0.454 Stannous Fluoride toothpaste with battery toothbrush

Test 1

regular fluoride toothpaste with battery toothbrush

Test 2

regular fluoride toothpaste with manual toothbrush

Test 3

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male and Female, age 18-70, inclusive.
  • Availability for the 12-week duration of the clinical research study.
  • Good general health at the discretion of the dental examiner or study investigators.
  • Minimum of 20 permanent natural teeth (excluding third molars).
  • Initial gingivitis index of at least 1.0 as determined by the use of the Loe and Silness Gingival Index.
  • Initial mean plaque index of at least 0.6 as determined by Rustogi Modification of the Navy plaque index.
  • Signed Informed Consent Form

You may not qualify if:

  • Presence of orthodontic appliances.
  • Presence of partial removable dentures.
  • Oral pathology, chronic disease or tumor(s) of the soft or hard tissues of the oral cavity.
  • Advanced periodontal disease (purulent exudate, tooth mobility, and/or extensive loss of periodontal attachment or alveolar bone).
  • Five or more carious lesions requiring immediate restorative treatment.
  • Use of anticonvulsants, sedatives, tranquilizers, anti-inflammatory or daily analgesics within one month prior to the start of the study or scheduled to start such intake during the course of the study.
  • Use of antibiotics any time during the one-month period prior to entry into the study.
  • Ongoing use of medications known to affect gingival tissues (i.e. calcium channel blockers, phenytoin, cyclosporine) and/or on any prescription medicines that might interfere with the study outcome.
  • Participation in any other clinical study.
  • Self-reported pregnancy and/or breastfeeding.
  • Dental prophylaxis within the past three weeks prior to baseline examinations.
  • Current allergies and/or history of allergic reactions to oral care products, personal care consumer products, or any of their ingredients.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dental Research Associates, Inc.

San Juan, 00927, Puerto Rico

Location

MeSH Terms

Conditions

Plaque, AmyloidGingivitis

Condition Hierarchy (Ancestors)

Pathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsInfectionsGingival DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Officials

  • Augusto R. Elias-Boneta, DMD.MSD

    Dental Research Associates

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 4, 2025

First Posted

November 5, 2025

Study Start

October 14, 2025

Primary Completion

January 28, 2026

Study Completion

January 28, 2026

Last Updated

February 6, 2026

Record last verified: 2026-02

Locations